◄ back to all posts

CBM: Cambrex Corp. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.00
Enterprise Value ($M) 411.67
Book Value ($M) 675.89
Book Value / Share 20.04
Price / Book 0.00
NCAV ($M) -424.72
NCAV / Share -12.59
Price / NCAV 0.00

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.17

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 2.37

Balance Sheet (mrq) ($M)
Current Assets 405.95
Assets 1,506.56
Liabilities 830.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 532.09
Operating Income 101.50
Net Income 92.42
Earnings Per Share Diluted 2.75
Earnings Per Share Basic 2.78

Cash Flow Statement (mra) ($M)
Cash From Operations 86.98
Cash from Investing -486.84
Cash from Financing -486.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-10 13G/A William Blair Investment Management, Llc 0.00 -100.00
2019-01-24 13G/A BlackRock Inc. 14.60 17.36
2019-01-10 13G/A Vanguard Group Inc 10.13 10.79
2018-02-05 13G/A Dimensional Fund Advisors Lp 4.22 -14.68
2015-02-02 13G/A Royce & Associates Lp 3.08
2014-01-07 13G/A Heartland Advisors Inc 4.90
2013-02-14 13G/A Neuberger Berman Group LLC 2.66
2012-02-14 13G/A Ameriprise Financial Inc 0.60
2012-02-14 13G/A WHV Investments, Inc. 4.23
2012-02-09 13G/A Snyder Capital Management L P 0.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
BHVN – Biohaven Pharmaceutical Holding BMY – Bristol-Myers Squibb Co.
BXLT – Baxalta Incorporated CTLT – Catalent Inc.
EBS – Emergent Biosolutions, Inc.


Financial data and stock pages provided by
Fintel.io





2018/07/06
◄ back to all posts

Retirement